Trial · NCT07203339
Registered outcomes24
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
21 to 24 of 24
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Secondary | Attention and Working Memory (Digit Span - WAIS-III) | Assessment timepoints: Baseline; Week 8 (Visit 4/after completing the four-week treatment with active [a-tDCS], sham [s-tDCS], or duloxetine) | Attention and working memory will be assessed using the Digit Span subtest of the WAIS-III. The total score is based on correct forward and backward digit recall, with higher scores indicating better performance. |
| Secondary | Processing Speed (Symbol Search - WAIS-III) | Assessment timepoints: Baseline; Week 8 (Visit 4/after completing the four-week treatment with active [a-tDCS], sham [s-tDCS], or duloxetine) | Processing speed will be assessed using the Symbol Search subtest of the WAIS-III. The outcome is a scaled score ranging from 1 to 19, with higher scores indicating faster processing. |
| Secondary | Inhibitory Control (Stop Signal Task) | Assessment timepoints: Baseline; Week 8 (Visit 4/after completing the four-week treatment with active [a-tDCS], sham [s-tDCS], or duloxetine) | Inhibitory control will be assessed using the Stop Signal Task. The primary outcome is Stop Signal Reaction Time (SSRT), measured in milliseconds. Lower reaction times indicate better inhibitory control. |
| Secondary | Cognitive Flexibility (Trail Making Test A and B) | Assessment timepoints: Baseline; Week 8 (Visit 4/after completing the four-week treatment with active [a-tDCS], sham [s-tDCS], or duloxetine) | Executive function and cognitive flexibility will be assessed using the Trail Making Test Parts A and B. The outcome is total time to completion in seconds. Longer completion times indicate worse performance. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07203339/registered?page=2